跳至主要内容
临床试验/NCT02537821
NCT02537821Unknown不适用

HLA Sensitization in Severely Burned Patients

University of Zurich1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
50
试验地点
1
主要终点
HLA antibody formation (HLA Sensitization) (Unit: PRA in %)

研究概览

简要总结

Primary goal of this study is the analysis of HLA (Human leucocyte antigen) formation in severly burned patients. Potential HLA triggers in the treatment of severely burned patients are blood products, assist devices or temporary allogeneic skin. Besides that, inflammatory markers, such as WBC (white blood cell count), CRP (C-reactive protein), PCT (Procalcitonin) and two novel biomarkers (PSP (pancreatic stone protein), ST2) are to be investigated in severely burned patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • severely burned patients in need for hospitalization

排除标准

  • hematologic diseases

结局指标

主要结局

HLA antibody formation (HLA Sensitization) (Unit: PRA in %)

时间窗: Change from Baseline (admission) in HLA antibody count at 2 weeks, 4 weeks, 3 months and 6 months

The degree of sensitization is reported as the percentage of CDC (Complement dependent Cytotoxicity) Panel Reactive Antibody (PRA). Unit is %.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验